Pranav Joshi
Viral vectors I Scale up I Technology Transfer I Suspension and Adherent Cell Culture I Early- and Late- Stage Viral Vectors Process Development | PAT | Process Intensification
- Role
- Associate Director, Upstream Cmc Sciences at GEMMA Biotherapeutics
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Pranav Joshi
Autonomous and accomplished bioprocess scientist with 9+ years of experience in improving biologics manufacturing technologies and passion for bringing a positive difference to a patient`s life.•Innovator and problem solver researcher with in-depth expertise in upstream-downstream processing, and analytics of AAV based gene therapy vector resulting in 7 scientific publications and 7 national-international conference presentations.•A team player and a collaborator with a proven track record of conceptualizing and transforming new ideas into viable solutions to meet prioritizing areas of business needs while retaining a strong interest in disseminating and presenting complex scientific information and data in meetings and forums to expert and non-expert audiences
Experience
Associate Director, Upstream Cmc Sciences
Oct 2024 — Present · King of Prussia, PA, US
Leading a small team of high-performing scientists for development of innovative AAV production technologies and execution of AAV manufacturing runs to support pre-clinical and first in human clinical trial studies. Oversaw multiple internal and external projects with a combined valuation exceeding $1 million, ensuring strategic alignment, technical excellence, and timely delivery across cross-functional stakeholdersSpearheading and authoring late-stage clinical development initiatives for Gemma Bio’s lead gene therapy candidate targeting an ultra-rare neurological disorder in infants. Responsibilities include driving strategy and execution to support clinical manufacturing readiness and preparing for regulatory submissions Managing the cell culture process development workstream for a multi-million-dollar project in collaboration with Brazil’s premier health research institute. Focused on advancing development activities and facilitating technology transfer for adeno-associated virus (AAV) gene therapy manufacturing platforms.Directed a late-stage clinical phase cell culture process development and characterization initiative for a sponsored gene therapy program targeting a pediatric genetic disorder. Contributed to advancing the drug candidate’s readiness for clinical manufacturing through supporting late stage continuous process improvement and characterization. Championed platform technology initiatives through close cross-functional collaboration with cell line development, downstream processing, and analytical teams within a highly matrixed organizational structure. Focused on driving innovation, integration, and scalability across therapeutic development pipelines.
Education
Sardar Patel University, Vallabh Vidyanagar
Bachelor of Pharmacy - B.Pharm., Pharmaceutical Sciences
2007 — 2011
Institute Of Chemical Technology
Master of Technology, M.Tech., Bioprocess Technology
2011 — 2013
McGill University
Doctor of Philosophy (PhD), Biological and Biomedical Engineering
2015 — 2021
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.